MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    RAB32 c.213C>G (p.Ser71Arg) explains Parkinson’s disease in two UK families: description of the clinical and biochemical features

    R. Tilney, R. Real, E. Gustavsson, S. Jasaityte, Y. Kordovska, M. Fenn, P. Korlipara, M. Hu, E. Sammler, M. Farrer, H. Morris (London, United Kingdom)

    Objective: To describe the clinical features, family structure of two families identified to have the recently described pathogenic variant RAB32 c.213C>G (p.Ser71Arg). Background: Genetic mutations…
  • 2024 International Congress

    Parkinson’s Families Project: A UK-Wide Study of Early Onset and Familial Parkinson’s Disease

    R. Real, Z-H. Fang, C. Towns, T. Schmaderer, S. Jasaityte, M. Tan, M. Pollard, L. Lange, R. Tilney, A. Singleton, C. Blauwendraat, C. Klein, H. Morris (London, United Kingdom)

    Objective: The Parkinson’s Families Project is a UK-wide study aimed at identifying genetic variation associated with familial and early-onset Parkinson's disease (PD). Background: Rare variants…
  • 2024 International Congress

    Bidirectional Relationship Between Olfaction and Parkinson’s Disease

    J. Kim, S. Bandres-Ciga, K. Heilbron, 23. INC., C. Blauwendraat, A. Noyce (London, United Kingdom)

    Objective: To establish a causal direction and genetic relationship between olfactory function and Parkinson’s disease (PD). Background: Degradation in olfactory function or hyposmia is a…
  • 2024 International Congress

    Clinical Features of dj1 Gene Mutation Causing Parkinson’s Disease from Single Institution

    H. Alhodaif, Y. Alkhodair, A. Aldakheel, S. Alqahtani, S. Boholegah (Riyadh, Saudi Arabia)

    Objective: Describe a detailed clinical and genetic evaluation of patients with Parkinson's disease secondary to DJ1 gene mutation Background: Inherited Parkinson's disease (PD) represents 5-10%…
  • 2023 International Congress

    Differential effect of dopaminergic medication on smooth pursuit vs. saccadic eye movements Parkinson’s disease

    M. Mlinarič, A. de Gobiss, V. Groznik, A. Sadikov, D. Georgiev (Ljubljana, Slovenia)

    Objective: To assess the effect of dopaminergic medication on eye movements in Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative disease, characterised…
  • 2023 International Congress

    transformation of essential tremor into Parkinson’s disease

    A. Mukhacheva, S. Staimets, N. Zhukova, YU. Lalov, I. Zhukova, L. Tkachenko, A. Agasheva, D. Novotniy (Omsk, Russian Federation)

    Objective: To study the percentage of transformation of the diagnosis of essential tremor (ET) into Parkinson's disease (PD) Background: during the initial onset of movement…
  • 2023 International Congress

    Questionnaire for the detection of Parkinson’s disease

    S. Abdraimova, R. Kaiyrzhanov, N. Zharkinbekova (Shymkent, Kazakhstan)

    Objective: The aim of this study was to develop a questionnaire for detecting Parkinson's disease in its early stages and to evaluate its effectiveness. Background:…
  • 2023 International Congress

    Marked reduction of energy supply due to levodopa treatment in patients with Parkinson’s disease and healthy controls

    J. Prasuhn, T. Schiefen, T. Grüber, J. Hekel, J. Uter, J. Steinhardt, B. Wilms, N. Brüggemann (Lübeck, Germany)

    Objective: To investigate the influence of a standardized, placebo-controlled administration of levodopa on cerebral bioenergetics in patients with Parkinson’s disease (PwPD) and healthy controls (HCs).…
  • 2023 International Congress

    Proteomic profiles analysis of plasma exosomes and WBC reveals news insights of PD patients classified into H&Y clinical stage

    BL. Fadel, N. Woldmar, G. Poralla, J. Fontes, L. Giacomin, M. Figueiredo, J. Evaristo, F. Nogueira, C. Panis, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

    Objective: To perform a comparative proteomic analysis of WBC and exosomes in samples from PD patients and to compare with healthy controls (HC) using a…
  • 2023 International Congress

    On-demand therapy (ODT) in Parkinson’s disease: a survey of advanced practice providers

    K. Papesh, A. Merriam, C. Zebendon (Phoenix, USA)

    Objective: A survey of neurology Advanced Practice Providers (APPs) provides insights into their perspectives on managing and treating patients with Parkinson’s disease (PD) in the…
  • « Previous Page
  • 1
  • …
  • 190
  • 191
  • 192
  • 193
  • 194
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley